Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Apicomplexan parasites use Ca-regulated exocytosis to secrete essential virulence factors from specialized organelles called micronemes. Ca-dependent protein kinases (CDPKs) are required for microneme exocytosis; however, the molecular events that regulate trafficking and fusion of micronemes with the plasma membrane remain unresolved. Here, we combine sub-minute resolution phosphoproteomics and bio-orthogonal labeling of kinase substrates in to identify 163 proteins phosphorylated in a CDPK1-dependent manner. In addition to known regulators of secretion, we identify uncharacterized targets with predicted functions across signaling, gene expression, trafficking, metabolism, and ion homeostasis. One of the CDPK1 targets is a putative HOOK activating adaptor. In other eukaryotes, HOOK homologs form the FHF complex with FTS and FHIP to activate dynein-mediated trafficking of endosomes along microtubules. We show the FHF complex is partially conserved in , consisting of HOOK, an FTS homolog, and two parasite-specific proteins (TGGT1_306920 and TGGT1_316650). CDPK1 kinase activity and HOOK are required for the rapid apical trafficking of micronemes as parasites initiate motility. Moreover, parasites lacking HOOK or FTS display impaired microneme protein secretion, leading to a block in the invasion of host cells. Taken together, our work provides a comprehensive catalog of CDPK1 targets and reveals how vesicular trafficking has been tuned to support a parasitic lifestyle.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629828PMC
http://dx.doi.org/10.7554/eLife.85654DOI Listing

Publication Analysis

Top Keywords

cdpk1 targets
12
microneme exocytosis
8
fhf complex
8
hook fts
8
trafficking
6
hook
5
analysis cdpk1
4
targets
4
targets identifies
4
identifies trafficking
4

Similar Publications

Anti-Cryptosporidium efficacy of BKI-1708, an inhibitor of Cryptosporidium calcium-dependent protein kinase 1.

PLoS Negl Trop Dis

July 2025

Department of Medicine, Division of Allergy and Infectious Diseases, Center for Emerging and Re-emerging Infectious Disease (CERID), University of Washington, Seattle, Washington, United States of America.

Background: Diarrheal pathogens, such as Cryptosporidium, impose a heavy burden of disease in resource-limited regions. Cryptosporidiosis often causes chronic infection in immunocompromised people and gastrointestinal injury in malnourished children, leading to wasting, stunting, and cognitive impairment. Current treatment for cryptosporidiosis fails in these vulnerable populations, highlighting the need for new medicines.

View Article and Find Full Text PDF

Toxoplasmosis, affecting one-third of the global human population, urgently requires new therapeutic strategies due to current treatment limitations and drug resistance. Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) is a promising drug target due to its essential role in parasite survival and its presumed unique glycine gatekeeper residue. Aiming at identifying new and selective inhibitors of TgCDPK1, we performed computational structural analyses and unexpectedly found that a human kinase (BUB1), despite having only 14% sequence identity, shares this glycine gatekeeper with TgCDPK1, which initially raised concerns for selective inhibitor development.

View Article and Find Full Text PDF

A subset of bumped kinase inhibitors (BKIs) has been optimized to inhibit the calcium dependent protein kinase 1 (CDPK1; TGGT1_301440) of and pathogenic species. Extensive preclinical development of BKIs has identified BKI-1748 as a highly effective lead compound for toxoplasmosis. Phenotypic and therapeutic effects of BKIs have suggested that BKIs may have targets other than CDPK1.

View Article and Find Full Text PDF

Gefitinib as an antimalarial: unveiling its therapeutic potential.

Inflammopharmacology

March 2025

Parasitology Laboratory, Department of Zoology, Panjab University, Chandigarh, 160014, India.

Resistant strains of Plasmodium spp. pose a great threat to healthcare. Drug repurposing is a smart, and an effective way to look for new alternatives for different ailments including malaria.

View Article and Find Full Text PDF

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases.

J Vis Exp

November 2024

Cellular and Molecular Parasitology Laboratory, School of Life Sciences, Jawaharlal Nehru University; Laboratory of Malaria and Vector Research and National Institutes of Allergy and Infectious Diseases, National Institutes of Health;

Article Synopsis
  • The malaria parasite can alter its transcriptome to resist the effects of drugs, particularly affecting multigene families.
  • CDPK family protein kinases in Plasmodium falciparum are crucial for its development and are potential targets for anti-malarial drugs.
  • By using a chemical genetics approach to study a mutant parasite with a modified cdpk1 gene, researchers aim to discover compensatory mechanisms that could be targeted to combat drug resistance.
View Article and Find Full Text PDF